NASDAQ:INKT

Mink Therapeutics Stock Insider Trading

etoro logo Buy INKT
*Your capital is at risk
$12.33
+0.0800 (+0.653%)
At Close: Jun 23, 2026

MiNK Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 69.57. In total, the insiders bought 761.33K and sold 24.23K INKT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
69.57
Buy 761.33K shares
Sell 24.23K shares
89% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Jun 04, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 69.57.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jan 02, 2026
Buy
Stock Option (Right to Buy)
A-Award
Buell Jennifer
Chief Executive Officer
CEO / President 50 000
Value: $556.0K
Jan 02, 2026
Buy
Common Stock
A-Award
Buell Jennifer
Chief Executive Officer
CEO / President 31 474
Value: $350.0K
Dec 01, 2025
Buy
Common Stock
A-Award
Wiinberg Ulf
Director
Director 1 263
Value: $14.0K
Dec 01, 2025
Buy
Common Stock
A-Award
Kadlec Robert Peter
Director
Director 1 218
Value: $13.5K
Dec 01, 2025
Buy
Common Stock
A-Award
Holcomb John Bradley
Director
Director 1 128
Value: $12.5K
Dec 01, 2025
Buy
Common Stock
A-Award
Ryan Barbara
Director
Director 1 601
Value: $17.8K
Dec 01, 2025
Buy
Common Stock
A-Award
Behner Peter
Director
Director 1 466
Value: $16.3K
Dec 01, 2025
Buy
Common Stock
A-Award
Corvese Brian
Director
Director 1 612
Value: $17.9K
Sep 23, 2025
Buy
Stock Option (Right to Buy)
A-Award
Holcomb John Bradley
Director
Director 4 174
Value: $62.3K
Sep 09, 2025
Sell
Common Stock
F-InKind
Buell Jennifer
Chief Executive Officer
CEO / President 5 351
Value: $82.2K
Sep 09, 2025
Sell
Common Stock
F-InKind
Buell Jennifer
Chief Executive Officer
CEO / President 5 351
Value: $82.2K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Buell Jennifer
Chief Executive Officer
CEO / President 50 000
Value: $768.0K
Sep 09, 2025
Buy
Common Stock
A-Award
Buell Jennifer
Chief Executive Officer
CEO / President 18 229
Value: $280.0K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Kadlec Robert Peter
Director
Director 3 225
Value: $49.5K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Behner Peter
Director
Director 3 225
Value: $49.5K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Buell Jennifer
Chief Executive Officer
CEO / President 50 000
Value: $768.0K
Sep 09, 2025
Buy
Common Stock
A-Award
Buell Jennifer
Chief Executive Officer
CEO / President 18 229
Value: $280.0K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Kadlec Robert Peter
Director
Director 3 225
Value: $49.5K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Behner Peter
Director
Director 3 225
Value: $49.5K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Corvese Brian
Director
Director 3 225
Value: $49.5K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Wiinberg Ulf
Director
Director 3 225
Value: $49.5K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Ryan Barbara
Director
Director 3 225
Value: $49.5K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Corvese Brian
Director
Director 3 225
Value: $49.5K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Wiinberg Ulf
Director
Director 3 225
Value: $49.5K
Sep 09, 2025
Buy
Stock Option (Right to Buy)
A-Award
Ryan Barbara
Director
Director 3 225
Value: $49.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MINK THERAPEUTICS, INC.
MiNK Therapeutics
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was former...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE